ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops year-round ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods ATCX is established in the rapidly growing […]

Plant-based e-commerce outlet and lifestyle educator PlantX Life is expanding across Canada and the United States through strategic acquisitions that make its products more accessible to consumers PlantX Life is based in British Columbia, Canada, with additional flagship operations in Southern California to serve the United States through its branded XMarket stores and online partnerships […]

SPYR was featured in a recent report highlighting the company’s intention to stake its claim in the burgeoning global Internet of Things market The company continues to identify and target acquisitions to potentially grow its footprint in the industry and increase its product offerings, the report notes SPYR also announced it had further expanded the […]

The company also participated in the H.C. Wainwright BioConnect Conference earlier in January CNS Pharmaceuticals recently received approval from swissethics for a pivotal Berubicin and GBM clinical trial The five-year survival rate for GBM is only 6.8%, with the average patient population surviving 12 to 18 months after diagnosis CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical […]

EverGen forecasts EBITDA growth from about C$3 million in 2021 to more than C$12 million in the next 12 months from expansion of core operating assets EverGen stock began trading in the U.S. on the OTCQB Venture Market under ticker symbol ‘EVGIF’ on February 15, 2022 EverGen has low-risk long term contracted or reoccurring revenue […]

Cepton, Inc formally listed on the Nasdaq Capital Market on February 11, 2022, following the merger between Cepton Technologies Inc., and SPAC, Growth Capital Acquisition Corp (GCAC) Cepton’s CEO, Dr. Jun Pei rang the Nasdaq opening bell on Thursday, February 17, alongside CTO Dr. Mark McCord and members of both, Cepton Technologies and Growth Capital […]

Psychedelic drugs are on cusp of entering mainstream treatment for mental illness Cybin, Chopra Foundation to collaborate on efforts aimed to support education, awareness about psychedelic therapy mental health research Cybin “one of the only companies that may truly address the needs of patients and providers,” says Dr. Deepak Chopra A significant increase in research […]

Companies and investors are invited to attend the Q1 2022 Virtual Investor Summit being held as a virtual event on March 8-9th, 2022.  The Investor Summit has been the largest independent conference on the East Coast for many years (formerly “The Microcap Conference”) and represents companies that are looking for a timely platform to connect […]

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company […]

SaaS company SRAX offers a robust suite of cutting-edge products that facilitate engagement between public companies and investors, both existing and potential SRAX forecasts a record first quarter of $11.5 million in revenue as part of 2022 revenue in the range of $46-$48 million The company bought back ~$800,000 during Q2 2021, paid a dividend […]